Enduring power of brand loyalty shown by survey

Generic drugs are known to be an effective cost-containment measure for healthcare systems.

But, in spite their increasing usage, a significant proportion of healthcare professionals (HCPs) still tend to favor branded drugs, finds GlobalData, a data and analytics company.

GlobalData’s survey Generic Drugs - Physician Perspective uncovered that if cost was not the primary factor, overall close to 40% of physicians would prescribe branded drugs for their patients. Physicians in Italy (45%), Spain (50%), and Japan (57%) particularly supported brand-name prescriptions.